Pharmaceutical Asset Strategic Analysis: Bexicaserin

Strategy document design communicating a comprehensive asset-level strategic plan for a pharmaceutical development programme. The document structures complex clinical data, market analysis, and commercial strategy, translating technical research into executive-ready insights.

Client: Velocity Insights
Role: Information Designer
Timeline: 1 week

More Projects

Interactive Talent Intelligence Charts

A series of interactive charts for Zeki’s talent intelligence work.…

Challenges of developing anti-drug antibody and concentration

Technical white paper translating complex bioanalytical challenges in gene therapy…

Commercial operations strategy input for a pharmaceutical board

An input deck for a pharmaceutical board, covering commercial analytics,…

Health Spending and Life Expectancy Gap

Data visualisation revealing the disconnect between healthcare expenditure and life…